STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Genesco (NYSE: GCO) Q3 2026: sales hit $616M as losses narrow year-to-date

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

Genesco Inc. reports modest top-line growth with improved profitability in its latest quarter. Net sales for the third quarter of Fiscal 2026 rose 3.3% to $616.2 million, driven by a 3% comparable sales increase and strong back-to-school performance at Journeys. Journeys Group sales grew 3.9% with operating margin improving to 5.5%, while Schuh and Johnston & Murphy faced softer comparable sales and margin pressure from promotions and tariffs. Net earnings from continuing operations were $5.4 million (diluted EPS $0.50), compared with a net loss of $18.9 million (diluted loss per share $1.76) a year earlier, helped by a more normal tax rate. For the first nine months, net sales increased to $1.64 billion and the net loss narrowed to $34.3 million from $53.3 million, as cost controls, store optimization and a U.S. tax refund partially offset margin headwinds.

Positive

  • None.

Negative

  • None.

Insights

Genesco shows improving earnings and tax benefits, but core retail margins remain pressured.

Genesco delivered 3.3% sales growth in Q3 Fiscal 2026 to $616.2M, with strength in Journeys Group offsetting weaker trends at Schuh and Johnston & Murphy. Journeys comparable sales rose 6% and its operating margin expanded to 5.5%, highlighting benefits from product assortment, higher conversion and cost controls. Company-wide operating margin, however, was only 1.4% as promotions and tariffs compressed gross margin to 46.8% of net sales.

Despite pressure on margins, bottom-line performance improved sharply. Net earnings reached $5.4M in the quarter versus a prior-year loss of $18.9M, aided by a more typical effective tax rate of 28.1% versus 311.5% last year, when a large U.S. valuation allowance was recorded. For the first nine months, net sales rose to $1.64B while the net loss narrowed to $34.3M, and the company recorded a 10.3% effective income tax rate reflecting the impact of the OBBBA tax legislation.

From a balance sheet perspective, total assets were $1.47B at November 1, 2025, with inventories elevated at $558.1M and long-term debt of $89.5M, including U.S. and U.K. revolver borrowings. Excess availability under the main Credit Facility was $256.5M, and the company received $58.3M of a U.S. tax refund during the period, supporting liquidity. Management continues to close underperforming stores, invest in key banners and prepare a Wrangler-branded footwear launch in Fall 2026, while restructuring and impairment charges of $4.7M weigh on near-term results.

--01-31Q30000018498false2026http://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrent0000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-11-010000018498us-gaap:RetainedEarningsMember2025-02-022025-05-030000018498us-gaap:PreferredStockMember2024-11-020000018498gco:UKRevolverBorrowingsMember2025-11-010000018498us-gaap:OperatingSegmentsMember2024-08-042024-11-020000018498us-gaap:AdditionalPaidInCapitalMember2024-05-052024-08-0300000184982024-02-042024-05-040000018498us-gaap:IntersegmentEliminationMembergco:JohnstonAndMurphyGroupSegmentMember2025-02-022025-11-010000018498us-gaap:IntersegmentEliminationMembergco:JourneysGroupSegmentMember2025-02-022025-11-010000018498gco:JourneysGroupSegmentMember2025-08-032025-11-010000018498us-gaap:SalesRevenueNetMembersrt:NorthAmericaMemberus-gaap:GeographicConcentrationRiskMember2025-08-032025-11-010000018498us-gaap:CommonStockMember2025-11-010000018498gco:RetailOccupancyCostsMember2025-02-022025-11-010000018498us-gaap:CommonStockMember2025-05-042025-08-020000018498us-gaap:RetainedEarningsMember2025-08-020000018498us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2024-08-042024-11-020000018498gco:FacilityAgreementMemberus-gaap:RevolvingCreditFacilityMembergco:SchuhAndLloydsBankPLCMember2025-11-010000018498us-gaap:PreferredStockMember2024-02-030000018498gco:RetailOccupancyCostsMember2024-02-042024-11-020000018498gco:UKRevolverBorrowingsMember2025-02-010000018498us-gaap:EmployeeSeveranceMember2024-02-042024-11-020000018498us-gaap:FairValueInputsLevel1Member2025-11-010000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-08-030000018498us-gaap:IntersegmentEliminationMember2025-08-032025-11-010000018498us-gaap:CorporateAndOtherMember2024-11-020000018498us-gaap:TreasuryStockCommonMember2024-05-040000018498us-gaap:IntersegmentEliminationMember2024-02-042024-11-020000018498us-gaap:SalesRevenueNetMembersrt:NorthAmericaMemberus-gaap:GeographicConcentrationRiskMember2025-02-022025-11-010000018498us-gaap:PreferredStockMember2025-02-010000018498country:CA2025-11-010000018498us-gaap:CorporateAndOtherMember2024-08-042024-11-020000018498gco:RetailOccupancyCostsMember2025-08-032025-11-010000018498us-gaap:CorporateAndOtherMember2024-02-042024-11-020000018498us-gaap:OtherIntangibleAssetsMember2025-11-010000018498gco:JourneysGroupSegmentMemberus-gaap:OperatingSegmentsMember2024-11-020000018498us-gaap:CommonStockMember2025-02-022025-05-030000018498us-gaap:CorporateAndOtherMember2025-11-010000018498us-gaap:PreferredStockMember2024-05-040000018498us-gaap:RetainedEarningsMember2024-08-042024-11-020000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2025-02-022025-11-010000018498gco:JourneysGroupSegmentMembergco:RetailStoreAssetImpairmentsMember2024-02-042024-11-020000018498gco:RetailOccupancyCostsMember2024-08-042024-11-020000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2025-08-032025-11-010000018498gco:SchuhGroupSegmentMember2024-02-042024-11-020000018498gco:StoreRestructuringMember2025-08-032025-11-010000018498us-gaap:AdditionalPaidInCapitalMember2024-11-020000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2024-08-042024-11-020000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2025-08-032025-11-010000018498gco:SchuhGroupSegmentMembergco:StoreRestructuringMember2025-08-032025-11-010000018498us-gaap:AdditionalPaidInCapitalMember2024-05-040000018498gco:StoreRestructuringMembergco:JourneysGroupSegmentMember2025-08-032025-11-0100000184982025-08-020000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2024-08-042024-11-020000018498us-gaap:TreasuryStockCommonMember2025-05-030000018498us-gaap:AdditionalPaidInCapitalMember2024-02-030000018498us-gaap:SalesRevenueNetMemberus-gaap:GeographicConcentrationRiskMembersrt:NorthAmericaMember2024-02-042024-11-020000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-052024-08-030000018498us-gaap:CommonStockMember2024-08-042024-11-020000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-08-042024-11-020000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2025-08-032025-11-010000018498us-gaap:CustomerListsMember2025-02-010000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2024-11-020000018498us-gaap:AdditionalPaidInCapitalMember2025-02-010000018498us-gaap:IntersegmentEliminationMembergco:JourneysGroupSegmentMember2025-08-032025-11-0100000184982024-02-030000018498us-gaap:RetainedEarningsMember2025-08-032025-11-010000018498us-gaap:OtherIntangibleAssetsMember2025-02-010000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2024-11-020000018498us-gaap:PreferredStockMember2024-08-030000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2025-11-010000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-02-010000018498us-gaap:CommonStockMember2024-02-030000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-11-020000018498us-gaap:TrademarksMember2025-11-010000018498gco:SchuhGroupSegmentMember2025-08-032025-11-010000018498gco:WholesaleCostsOfDistributionMember2025-02-022025-11-010000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2025-02-022025-11-010000018498us-gaap:CommonStockMember2024-05-052024-08-0300000184982025-08-032025-11-0100000184982024-02-042024-11-020000018498us-gaap:RetainedEarningsMember2025-02-010000018498gco:JourneysGroupSegmentMember2024-08-042024-11-0200000184982024-11-0200000184982024-08-042024-11-020000018498gco:JohnstonAndMurphyGroupSegmentMember2024-02-042024-11-020000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2025-08-032025-11-010000018498us-gaap:OperatingSegmentsMember2025-08-032025-11-010000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-040000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-02-022025-05-030000018498us-gaap:PreferredStockMember2025-08-020000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2024-02-042024-11-020000018498gco:JohnstonAndMurphyGroupSegmentMember2024-08-042024-11-020000018498gco:JohnstonAndMurphyGroupSegmentMember2025-02-022025-11-010000018498us-gaap:CommonStockMember2024-02-042024-05-040000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2024-02-042024-11-020000018498gco:GenescoBrandsSegmentMember2025-02-022025-11-0100000184982025-05-042025-08-020000018498us-gaap:AdditionalPaidInCapitalMember2025-02-022025-05-030000018498us-gaap:RetainedEarningsMember2024-02-030000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2025-02-022025-11-010000018498gco:StoreRestructuringMembergco:JourneysGroupSegmentMember2025-02-022025-11-010000018498us-gaap:TrademarksMember2025-02-010000018498us-gaap:OperatingSegmentsMember2024-02-042024-11-020000018498us-gaap:AdditionalPaidInCapitalMember2025-08-020000018498us-gaap:AdditionalPaidInCapitalMember2024-08-042024-11-020000018498us-gaap:CommonStockMember2024-08-030000018498us-gaap:AdditionalPaidInCapitalMember2025-05-030000018498us-gaap:EmployeeSeveranceMember2025-02-022025-11-010000018498us-gaap:CommonStockMember2025-08-020000018498gco:SchuhGroupSegmentMembergco:AssetImpairmentMember2025-08-032025-11-0100000184982025-11-280000018498us-gaap:PreferredStockMember2025-05-0300000184982025-11-010000018498us-gaap:IntersegmentEliminationMembergco:JohnstonAndMurphyGroupSegmentMember2024-02-042024-11-020000018498us-gaap:SalesRevenueNetMembersrt:NorthAmericaMemberus-gaap:GeographicConcentrationRiskMember2024-08-042024-11-020000018498us-gaap:AdditionalPaidInCapitalMember2024-02-042024-05-040000018498us-gaap:TreasuryStockCommonMember2025-02-0100000184982025-02-022025-11-010000018498gco:JourneysGroupSegmentMember2024-02-042024-11-020000018498gco:USRevolverBorrowingsMember2025-02-010000018498us-gaap:CommonStockMember2025-05-030000018498gco:GenescoBrandsSegmentMember2025-08-032025-11-0100000184982025-02-010000018498gco:JourneysGroupSegmentMemberus-gaap:IntersegmentEliminationMember2024-02-042024-11-020000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2024-08-042024-11-020000018498gco:USRevolverBorrowingsMember2025-11-010000018498us-gaap:RetainedEarningsMember2025-05-042025-08-020000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2024-08-042024-11-020000018498us-gaap:PreferredStockMember2024-08-042024-11-020000018498gco:SchuhGroupSegmentMember2025-02-022025-11-010000018498gco:SchuhGroupSegmentMember2024-08-042024-11-0200000184982024-05-052024-08-0300000184982025-02-022025-05-030000018498us-gaap:TreasuryStockCommonMember2024-11-020000018498us-gaap:IntersegmentEliminationMember2024-08-042024-11-020000018498us-gaap:RevolvingCreditFacilityMembergco:GenescoCanadaUlcMember2025-11-010000018498us-gaap:CommonStockMember2024-05-040000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2024-02-042024-11-020000018498gco:SchuhGroupSegmentMembergco:AssetImpairmentMember2025-02-022025-11-010000018498country:CA2024-11-020000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-05-030000018498gco:JourneysGroupSegmentMembergco:RetailStoreAssetImpairmentsMember2024-08-042024-11-020000018498country:GB2025-11-010000018498gco:GenescoBrandsSegmentMember2024-02-042024-11-020000018498us-gaap:CommonStockMember2024-11-020000018498gco:StoreRestructuringMember2025-02-022025-11-010000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2025-02-022025-11-010000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2024-11-020000018498us-gaap:RetainedEarningsMember2025-05-030000018498us-gaap:TreasuryStockCommonMember2025-08-020000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2025-08-032025-11-010000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-08-020000018498gco:WholesaleCostsOfDistributionMember2025-08-032025-11-010000018498gco:SchuhGroupSegmentMembergco:StoreRestructuringMember2025-02-022025-11-010000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2024-02-042024-11-020000018498us-gaap:AdditionalPaidInCapitalMember2024-08-030000018498us-gaap:AdditionalPaidInCapitalMember2025-05-042025-08-020000018498us-gaap:RetainedEarningsMember2024-05-052024-08-030000018498gco:JourneysGroupSegmentMemberus-gaap:OperatingSegmentsMember2025-11-010000018498gco:JourneysGroupSegmentMember2025-02-022025-11-010000018498us-gaap:RevolvingCreditFacilityMembergco:USRevolverBorrowingsMember2025-11-0100000184982024-08-030000018498us-gaap:OperatingSegmentsMember2025-02-022025-11-010000018498us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2025-08-032025-11-010000018498us-gaap:RetainedEarningsMember2025-11-010000018498us-gaap:RetainedEarningsMember2024-11-020000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2024-08-042024-11-020000018498gco:WholesaleCostsOfDistributionMember2024-02-042024-11-020000018498us-gaap:RetainedEarningsMember2024-05-0400000184982024-05-040000018498gco:JohnstonAndMurphyGroupSegmentMember2025-08-032025-11-010000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2025-02-022025-11-010000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-05-042025-08-020000018498us-gaap:TreasuryStockCommonMember2024-02-030000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-030000018498gco:JourneysGroupSegmentMemberus-gaap:IntersegmentEliminationMember2024-08-042024-11-020000018498us-gaap:FairValueInputsLevel3Member2025-11-010000018498us-gaap:PreferredStockMember2024-02-042024-05-040000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2024-02-042024-11-020000018498us-gaap:IntersegmentEliminationMembergco:JohnstonAndMurphyGroupSegmentMember2025-08-032025-11-010000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2025-02-022025-11-0100000184982025-05-030000018498us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2024-02-042024-11-020000018498us-gaap:PreferredStockMember2025-11-010000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2024-08-042024-11-020000018498us-gaap:EmployeeSeveranceMember2025-08-032025-11-010000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2024-02-042024-11-020000018498us-gaap:TreasuryStockCommonMember2025-11-010000018498gco:WholesaleCostsOfDistributionMember2024-08-042024-11-020000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-042024-05-040000018498country:GB2024-11-020000018498us-gaap:RetainedEarningsMember2024-02-042024-05-040000018498us-gaap:RevolvingCreditFacilityMember2025-11-010000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2025-11-010000018498us-gaap:IntersegmentEliminationMember2025-02-022025-11-010000018498us-gaap:CommonStockMember2025-02-010000018498us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2025-02-022025-11-010000018498us-gaap:CorporateAndOtherMember2025-08-032025-11-010000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2025-11-010000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2025-08-032025-11-010000018498us-gaap:CorporateAndOtherMember2025-02-022025-11-010000018498us-gaap:CustomerListsMember2025-11-010000018498us-gaap:IntersegmentEliminationMembergco:JohnstonAndMurphyGroupSegmentMember2024-08-042024-11-020000018498us-gaap:TreasuryStockCommonMember2024-08-030000018498us-gaap:AdditionalPaidInCapitalMember2025-11-010000018498gco:GenescoBrandsSegmentMember2024-08-042024-11-020000018498us-gaap:AdditionalPaidInCapitalMember2025-08-032025-11-010000018498us-gaap:RetainedEarningsMember2024-08-030000018498us-gaap:CommonStockMember2025-08-032025-11-010000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-08-032025-11-01iso4217:USDxbrli:sharesxbrli:purexbrli:sharesiso4217:CADgco:Segmentgco:Storeiso4217:GBPiso4217:USD

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended November 1, 2025

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

Commission File No. 1-3083

Genesco Inc.

(Exact name of registrant as specified in its charter)

Tennessee

62-0211340

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

 

 

535 Marriott Drive

 

37214

Nashville,

Tennessee

 

(Zip Code)

(Address of principal executive offices)

 

 

 

Registrant's telephone number, including area code: (615) 367-7000

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1.00 par value

GCO

New York Stock Exchange

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer; an accelerated filer; a non-accelerated filer; a smaller reporting company; or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes No

As of November 28, 2025, there were 10,792,736 shares of the registrant's common stock outstanding.

 


 

INDEX

 

Part I. Financial Information

Item 1. Financial Statements:

Condensed Consolidated Balance Sheets - November 1, 2025, February 1, 2025 and November 2, 2024

4

Condensed Consolidated Statements of Operations - Three and Nine Months ended November 1, 2025 and November 2, 2024

5

Condensed Consolidated Statements of Comprehensive Income (Loss) - Three and Nine Months ended November 1, 2025 and November 2, 2024

6

Condensed Consolidated Statements of Cash Flows - Nine Months ended November 1, 2025 and November 2, 2024

7

Condensed Consolidated Statements of Equity - Three and Nine Months ended November 1, 2025 and November 2, 2024

8

Notes to Condensed Consolidated Financial Statements

9

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

17

Item 3. Quantitative and Qualitative Disclosures about Market Risk

25

Item 4. Controls and Procedures

25

Part II. Other Information

26

Item 1. Legal Proceedings

26

Item 1A. Risk Factors

26

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

27

Item 5. Other Information

27

Item 6. Exhibits

28

Signature

29

 

 

 

2


 

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q include certain forward-looking statements, which include statements regarding our intent, belief or expectations and all statements other than those made solely with respect to historical fact. Actual results could differ materially from those reflected by the forward-looking statements in this Quarterly Report on Form 10-Q and a number of factors may adversely affect the forward-looking statements and our future results, liquidity, capital resources or prospects. These include, but are not limited to, adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store, e-commerce and shopping mall traffic, the imposition of tariffs (including the timing and amount thereof) on products imported by us or our vendors as well as the ability and costs to move production of products in response to tariffs, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements and limitations on our ability to adequately staff and operate stores. Differences from expectations could also result from store closures and effects on the business as a result of the level of consumer spending on our merchandise and interest in our brands and in general; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; our ability to pass on price increases to our customers; the timing and amount of any share repurchases by us; our ability to obtain from suppliers products that are in demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events, including shipping disruptions near crucial trade routes; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs; a disruption in shipping or increase in cost of our imported products, and other factors affecting the cost of products; our dependence on third-party vendors and licensors for the products we sell; our ability to renew our license agreements; impacts of the Russia-Ukraine war, the conflict in Israel and the surrounding areas; market weakness in the locations in which we operate; the effectiveness of our omni-channel initiatives; costs associated with changes in minimum wage and overtime requirements; wage pressures; labor shortages; the effects of inflation; the evolving regulatory landscape related to our use of social media; the establishment and protection of our intellectual property; weakness in the consumer economy and retail industry; competition and fashion trends in our markets, including trends with respect to the popularity of casual and dress footwear; any failure to increase sales at our existing stores, given our high fixed expense cost structure, and in our e-commerce businesses; risks related to the potential for terrorist events; store closures and effects on the business as a result of civil disturbances; risks related to public health and safety events; changes in buying patterns by significant wholesale customers; changes in consumer preferences; our ability to continue to complete and integrate acquisitions; our ability to expand our business and diversify our product base; impairment of goodwill in connection with acquisitions; payment related risks that could increase our operating cost, expose us to fraud or theft, subject us to potential liability and disrupt our business; retained liabilities associated with divestitures of businesses including potential liabilities under leases as the prior tenant or as a guarantor of certain leases; and changes in the timing of holidays or in the onset of seasonal weather affecting period-to-period sales comparisons. Additional factors that could cause differences from expectations include the ability to secure allocations to refine product assortments to address consumer demand; the ability to renew leases in existing stores and control or lower occupancy costs, to open or close stores in the number and on the planned schedule, and to conduct required remodeling or refurbishment on schedule and at expected expense levels; our ability to realize anticipated cost savings, including rent savings; the timing and amount of any share repurchases by us; our ability to make our occupancy costs more variable; our ability to achieve expected digital gains and gain market share; changes in tax laws and tax rates and our ability to realize any anticipated tax benefits in both the amount and timeframe anticipated; deterioration in the performance of individual businesses or of our market value relative to our book value, resulting in impairments of fixed assets, operating lease right of use assets or intangible assets or other adverse financial consequences and the timing and amount of such impairments or other consequences; unexpected changes to the market for our shares or for the retail sector in general; costs and reputational harm as a result of disruptions in our business or information technology systems either by security breaches and incidents or by potential problems associated with the implementation of new or upgraded systems, and the cost and outcome of litigation, investigations, environmental matters and other disputes that involve us. For a full discussion of risk factors, see Part II, Item 1A, "Risk Factors" of this Quarterly Report on Form 10-Q.

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Part I, Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025 which should be read in conjunction with the risk factors in Part II, Item 1A and the forward-looking statements in this Quarterly Report on Form 10-Q. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

We maintain a website at www.genesco.com where investors and other interested parties may obtain, free of charge, press releases and other information as well as gain access to our periodic filings with the Securities and Exchange Commission (“SEC”). The information contained on this website should not be considered to be a part of this or any other report filed with or furnished to the SEC.

3


 

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

 

Genesco Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

 

Assets

 

November 1, 2025

 

 

February 1, 2025

 

 

November 2, 2024

 

Current Assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

27,034

 

 

$

34,007

 

 

$

33,578

 

Accounts receivable, net of allowances of $2,794 at November 1, 2025,

 

 

 

 

 

 

 

 

 

   $2,522 at February 1, 2025 and $2,591 at November 2, 2024

 

 

55,830

 

 

 

48,865

 

 

 

52,373

 

Inventories

 

 

558,059

 

 

 

425,224

 

 

 

523,152

 

Prepaids and other current assets

 

 

48,211

 

 

 

100,660

 

 

 

50,600

 

Total current assets

 

 

689,134

 

 

 

608,756

 

 

 

659,703

 

Property and equipment, net

 

 

241,070

 

 

 

228,022

 

 

 

230,090

 

Operating lease right of use assets

 

 

480,247

 

 

 

438,273

 

 

 

424,886

 

Non-current prepaid income taxes

 

 

 

 

 

 

 

 

58,670

 

Goodwill

 

 

9,176

 

 

 

8,863

 

 

 

9,230

 

Other intangibles

 

 

27,005

 

 

 

26,059

 

 

 

27,214

 

Deferred income taxes

 

 

389

 

 

 

389

 

 

 

339

 

Other noncurrent assets

 

 

25,082

 

 

 

25,174

 

 

 

25,389

 

Total Assets

 

 

1,472,103

 

 

 

1,335,536

 

 

 

1,435,521

 

Liabilities and Equity

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

212,668

 

 

 

168,077

 

 

 

214,935

 

Current portion - long-term debt

 

 

19,727

 

 

 

 

 

 

 

Current portion - operating lease liabilities

 

 

120,156

 

 

 

124,010

 

 

 

123,397

 

Other accrued liabilities

 

 

83,412

 

 

 

87,695

 

 

 

83,750

 

Total current liabilities

 

 

435,963

 

 

 

379,782

 

 

 

422,082

 

Long-term debt

 

 

69,774

 

 

 

 

 

 

100,114

 

Long-term operating lease liabilities

 

 

404,009

 

 

 

361,079

 

 

 

348,672

 

Other long-term liabilities

 

 

48,582

 

 

 

47,705

 

 

 

47,749

 

Total liabilities

 

 

958,328

 

 

 

788,566

 

 

 

918,617

 

Commitments and contingent liabilities

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

Non-redeemable preferred stock

 

 

835

 

 

 

835

 

 

 

823

 

Common equity:

 

 

 

 

 

 

 

 

 

Common stock, $1 par value:

 

 

 

 

 

 

 

 

 

Authorized: 80,000,000 shares

 

 

 

 

 

 

 

 

 

 Issued common stock

 

 

11,281

 

 

 

11,773

 

 

 

11,701

 

Additional paid-in capital

 

 

340,723

 

 

 

331,756

 

 

 

328,760

 

Retained earnings

 

 

218,286

 

 

 

265,887

 

 

 

231,997

 

Accumulated other comprehensive loss

 

 

(39,493

)

 

 

(45,424

)

 

 

(38,520

)

Treasury shares, at cost (488,464 shares)

 

 

(17,857

)

 

 

(17,857

)

 

 

(17,857

)

Total equity

 

 

513,775

 

 

 

546,970

 

 

 

516,904

 

Total Liabilities and Equity

 

$

1,472,103

 

 

$

1,335,536

 

 

$

1,435,521

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

4


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

November 1, 2025

 

 

November 2, 2024

 

 

November 1, 2025

 

 

November 2, 2024

 

Net sales

 

$

616,217

 

 

$

596,328

 

 

$

1,636,155

 

 

$

1,579,113

 

Cost of sales

 

 

327,589

 

 

 

311,072

 

 

 

876,397

 

 

 

831,937

 

Gross margin

 

 

288,628

 

 

 

285,256

 

 

 

759,758

 

 

 

747,176

 

Selling and administrative expenses

 

 

275,720

 

 

 

274,912

 

 

 

789,020

 

 

 

777,878

 

Asset impairments and other, net

 

 

4,332

 

 

 

134

 

 

 

4,747

 

 

 

1,490

 

Operating income (loss)

 

 

8,576

 

 

 

10,210

 

 

 

(34,009

)

 

 

(32,192

)

Other components of net periodic benefit cost

 

 

149

 

 

 

86

 

 

 

477

 

 

 

281

 

Interest expense, net

 

 

884

 

 

 

1,213

 

 

 

3,682

 

 

 

3,448

 

Earnings (loss) from continuing operations before income taxes

 

 

7,543

 

 

 

8,911

 

 

 

(38,168

)

 

 

(35,921

)

Income tax expense (benefit)

 

 

2,121

 

 

 

27,759

 

 

 

(3,922

)

 

 

17,144

 

Earnings (loss) from continuing operations

 

 

5,422

 

 

 

(18,848

)

 

 

(34,246

)

 

 

(53,065

)

Loss from discontinued operations, net of tax

 

 

(66

)

 

 

(84

)

 

 

(96

)

 

 

(206

)

Net Earnings (Loss)

 

$

5,356

 

 

$

(18,932

)

 

$

(34,342

)

 

$

(53,271

)

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.52

 

 

$

(1.76

)

 

$

(3.30

)

 

$

(4.88

)

Discontinued operations

 

 

0.00

 

 

 

0.00

 

 

 

(0.01

)

 

 

(0.02

)

Net earnings (loss)

 

$

0.52

 

 

$

(1.76

)

 

$

(3.31

)

 

$

(4.90

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.51

 

 

$

(1.76

)

 

$

(3.30

)

 

$

(4.88

)

Discontinued operations

 

 

(0.01

)

 

 

0.00

 

 

 

(0.01

)

 

 

(0.02

)

Net earnings (loss)

 

$

0.50

 

 

$

(1.76

)

 

$

(3.31

)

 

$

(4.90

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

10,334

 

 

 

10,737

 

 

 

10,374

 

 

 

10,870

 

Diluted

 

 

10,674

 

 

 

10,737

 

 

 

10,374

 

 

 

10,870

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

5


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Loss)

(In thousands)

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

November 1, 2025

 

 

November 2, 2024

 

 

November 1, 2025

 

 

November 2, 2024

 

Net earnings (loss)

 

$

5,356

 

 

$

(18,932

)

 

$

(34,342

)

 

$

(53,271

)

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

Postretirement liability adjustments

 

 

85

 

 

 

21

 

 

 

278

 

 

 

80

 

Foreign currency translation adjustments

 

 

(1,158

)

 

 

625

 

 

 

5,653

 

 

 

1,024

 

Total other comprehensive income (loss)

 

 

(1,073

)

 

 

646

 

 

 

5,931

 

 

 

1,104

 

Comprehensive Income (Loss)

 

$

4,283

 

 

$

(18,286

)

 

$

(28,411

)

 

$

(52,167

)

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

6


 

 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In thousands)

 

 

 

Nine Months Ended

 

 

 

November 1, 2025

 

 

November 2, 2024

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Net loss

 

$

(34,342

)

 

$

(53,271

)

Adjustments to reconcile net loss to net cash used in

 

 

 

 

 

 

operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

40,228

 

 

 

39,460

 

Deferred income taxes

 

 

626

 

 

 

26,921

 

Impairment of long-lived assets

 

 

3,896

 

 

 

494

 

Share-based compensation expense

 

 

9,080

 

 

 

9,767

 

Other

 

 

1,379

 

 

 

724

 

Changes in working capital and other assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(6,943

)

 

 

1,371

 

Inventories

 

 

(128,436

)

 

 

(143,647

)

Prepaids and other current assets

 

 

52,972

 

 

 

(10,828

)

Accounts payable

 

 

46,447

 

 

 

99,322

 

Other accrued liabilities

 

 

(8,388

)

 

 

6,051

 

Other assets and liabilities

 

 

(4,116

)

 

 

(5,472

)

Net cash used in operating activities

 

 

(27,597

)

 

 

(29,108

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

Capital expenditures

 

 

(52,185

)

 

 

(27,397

)

Proceeds from asset sales

 

 

 

 

 

1

 

Net cash used in investing activities

 

 

(52,185

)

 

 

(27,396

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

Borrowings under revolving credit facility

 

 

383,390

 

 

 

344,303

 

Payments on revolving credit facility

 

 

(294,044

)

 

 

(278,779

)

Shares repurchased related to share repurchase plan

 

 

(12,566

)

 

 

(9,789

)

Shares repurchased related to taxes for share-based awards

 

 

(1,206

)

 

 

(2,074

)

Change in overdraft balances

 

 

(3,129

)

 

 

882

 

Additions to deferred financing costs

 

 

(10

)

 

 

 

Net cash provided by financing activities

 

 

72,435

 

 

 

54,543

 

Effect of foreign exchange rate fluctuations on cash

 

 

374

 

 

 

384

 

Net decrease in cash and cash equivalents

 

 

(6,973

)

 

 

(1,577

)

Cash and cash equivalents at beginning of period

 

 

34,007

 

 

 

35,155

 

Cash and cash equivalents at end of period

 

$

27,034

 

 

$

33,578

 

Supplemental information:

 

 

 

 

 

 

Interest paid

 

$

3,359

 

 

$

3,290

 

Income taxes paid (received)

 

 

(56,141

)

 

 

2,275

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

 

 

 

 

 

 

 

 

 

 

 

7


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Equity

(In thousands)

 

 

Non-
Redeemable
Preferred
Stock

 

Common
Stock

 

Additional
Paid-In
Capital

 

Retained
Earnings

 

Accumulated
Other
Comprehensive
Loss

 

Treasury
Shares

 

Total
Equity

 

Balance February 3, 2024

$

813

 

$

11,961

 

$

319,143

 

$

296,766

 

$

(39,624

)

$

(17,857

)

$

571,202

 

Net loss

 

 

 

 

 

 

 

(24,347

)

 

 

 

 

 

(24,347

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

(935

)

 

 

 

(935

)

Share-based compensation expense

 

 

 

 

 

3,307

 

 

 

 

 

 

 

 

3,307

 

Restricted stock issuance

 

 

 

198

 

 

(198

)

 

 

 

 

 

 

 

 

Restricted shares withheld for taxes

 

 

 

(29

)

 

29

 

 

(773

)

 

 

 

 

 

(773

)

Other

 

(1

)

 

(8

)

 

7

 

 

1

 

 

 

 

 

 

(1

)

 Balance May 4, 2024

 

812

 

 

12,122

 

 

322,288

 

 

271,647

 

 

(40,559

)

 

(17,857

)

 

548,453

 

Net loss

 

 

 

 

 

 

 

(9,992

)

 

 

 

 

 

(9,992

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

1,393

 

 

 

 

1,393

 

Share-based compensation expense

 

 

 

 

 

3,453

 

 

 

 

 

 

 

 

3,453

 

Restricted stock issuance

 

 

 

37

 

 

(37

)

 

 

 

 

 

 

 

 

Shares repurchased

 

 

 

(382

)

 

 

 

(8,967

)

 

 

 

 

 

(9,349

)

Excise taxes related to repurchases of common stock

 

 

 

 

 

 

 

(35

)

 

 

 

 

 

(35

)

Restricted shares withheld for taxes

 

 

 

(49

)

 

49

 

 

(1,301

)

 

 

 

 

 

(1,301

)

Other

 

 

 

(21

)

 

22

 

 

(1

)

 

 

 

 

 

 

Balance August 3, 2024

 

812

 

 

11,707

 

 

325,775

 

 

251,351

 

 

(39,166

)

 

(17,857

)

 

532,622

 

Net loss

 

 

 

 

 

 

 

(18,932

)

 

 

 

 

 

(18,932

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

646

 

 

 

 

646

 

Share-based compensation expense

 

 

 

 

 

3,007

 

 

 

 

 

 

 

 

3,007

 

Restricted stock issuance

 

 

 

15

 

 

(15

)

 

 

 

 

 

 

 

 

Shares repurchased

 

 

 

(18

)

 

 

 

(421

)

 

 

 

 

 

(439

)

Other

 

11

 

 

(3

)

 

(7

)

 

(1

)

 

 

 

 

 

 

Balance November 2, 2024

$

823

 

$

11,701

 

$

328,760

 

$

231,997

 

$

(38,520

)

$

(17,857

)

$

516,904

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-
Redeemable
Preferred
Stock

 

Common
Stock

 

Additional
Paid-In
Capital

 

Retained
Earnings

 

Accumulated
Other
Comprehensive
Loss

 

Treasury
Shares

 

Total
Equity

 

Balance February 1, 2025

$

835

 

$

11,773

 

$

331,756

 

$

265,887

 

$

(45,424

)

$

(17,857

)

$

546,970

 

Net loss

 

 

 

 

 

 

 

(21,227

)

 

 

 

 

 

(21,227

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

6,724

 

 

 

 

6,724

 

Share-based compensation expense

 

 

 

 

 

2,994

 

 

 

 

 

 

 

 

2,994

 

Restricted stock issuance

 

 

 

141

 

 

(141

)

 

 

 

 

 

 

 

 

Restricted shares withheld for taxes

 

 

 

(36

)

 

36

 

 

(664

)

 

 

 

 

 

(664

)

Shares repurchased

 

 

 

(605

)

 

 

 

(11,961

)

 

 

 

 

 

(12,566

)

Other

 

 

 

(5

)

 

6

 

 

 

 

 

 

 

 

1

 

Balance May 3, 2025

 

835

 

 

11,268

 

 

334,651

 

 

232,035

 

 

(38,700

)

 

(17,857

)

 

522,232

 

Net loss

 

 

 

 

 

 

 

(18,471

)

 

 

 

 

 

(18,471

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

280

 

 

 

 

280

 

Share-based compensation expense

 

 

 

 

 

2,918

 

 

 

 

 

 

 

 

2,918

 

Restricted stock issuance

 

 

 

45

 

 

(45

)

 

 

 

 

 

 

 

 

Excise taxes related to repurchases of common stock

 

 

 

 

 

 

 

(92

)

 

 

 

 

 

(92

)

Restricted shares withheld for taxes

 

 

 

(24

)

 

24

 

 

(495

)

 

 

 

 

 

(495

)

Other

 

 

 

(4

)

 

4

 

 

 

 

 

 

 

 

 

 Balance August 2, 2025

 

835

 

 

11,285

 

 

337,552

 

 

212,977

 

 

(38,420

)

 

(17,857

)

 

506,372

 

Net earnings

 

 

 

 

 

 

 

5,356

 

 

 

 

 

 

5,356

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

(1,073

)

 

 

 

(1,073

)

Share-based compensation expense

 

 

 

 

 

3,167

 

 

 

 

 

 

 

 

3,167

 

Restricted shares withheld for taxes

 

 

 

(2

)

 

2

 

 

(47

)

 

 

 

 

 

(47

)

Other

 

 

 

(2

)

 

2

 

 

 

 

 

 

 

 

 

Balance November 1, 2025

$

835

 

$

11,281

 

$

340,723

 

$

218,286

 

$

(39,493

)

$

(17,857

)

$

513,775

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

8


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 1

Summary of Significant Accounting Policies

Basis of Presentation

These Condensed Consolidated Financial Statements should be read in conjunction with our Consolidated Financial Statements and Notes for Fiscal 2025, which are contained in our Annual Report on Form 10-K as filed with the SEC on March 26, 2025. The Condensed Consolidated Financial Statements and Notes contained in this report are unaudited but reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation of the results for the interim periods of the fiscal year ending January 31, 2026 ("Fiscal 2026") and of the fiscal year ended February 1, 2025 ("Fiscal 2025"), both of which are 52-week years. All subsidiaries are consolidated in the Condensed Consolidated Financial Statements. All significant intercompany transactions and accounts have been eliminated. The results of operations for any interim period are not necessarily indicative of results for the full year. The Condensed Consolidated Financial Statements and the related Notes have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. The Condensed Consolidated Balance Sheet as of February 1, 2025 has been derived from the audited financial statements at that date.

Nature of Operations

Genesco Inc. and its subsidiaries (collectively the "Company", "Genesco," "we", "our", or "us") business includes the sourcing and design, marketing and distribution of footwear, apparel and accessories through retail stores in the U.S., Puerto Rico and Canada primarily under the Journeys®, Journeys Kidz®, Little Burgundy® and Johnston & Murphy® banners and under the Schuh® banner in the United Kingdom (“U.K.”) and the Republic of Ireland (“ROI”); through e-commerce websites including the following: journeys.com, journeyskidz.com, journeys.ca, littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com and nashvilleshoewarehouse.com as well as the Johnston & Murphy catalog. We also source, design, market and distribute footwear, apparel and accessories at wholesale, primarily under our Johnston & Murphy brand, the licensed Levi's® brand, the licensed Dockers® brand and other brands that we license for footwear. At November 1, 2025, we operated 1,245 retail stores in the U.S., Puerto Rico, Canada, the U.K. and the ROI.

During the three and nine months ended November 1, 2025 and November 2, 2024, we operated four reportable business segments (not including corporate): (i) Journeys Group, comprised of the Journeys, Journeys Kidz and Little Burgundy retail footwear chains and e-commerce operations; (ii) Schuh Group, comprised of the Schuh retail footwear chain and e-commerce operations; (iii) Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and wholesale distribution of products under the Johnston & Murphy brand; and (iv) Genesco Brands Group, comprised of the licensed Dockers and Levi's brands, as well as other brands we license for footwear. Our license with Levi's expires in the spring of 2026 and we are in the process of exiting that business during Fiscal 2026.

During the second quarter of Fiscal 2026, we signed a multi-year licensing agreement with Kontoor Brands, Inc. to design, source, market and distribute men's, women's and children's footwear under the Wrangler® brand ("Wrangler"). We expect to launch the first Wrangler footwear collection under the licensing agreement in the Fall of 2026.

Selling and Administrative Expenses

Wholesale costs of distribution are included in selling and administrative expenses on the Condensed Consolidated Statements of Operations in the amount of $2.6 million and $2.4 million for the third quarters of Fiscal 2026 and Fiscal 2025, respectively, and $7.9 million and $7.4 million for the first nine months of Fiscal 2026 and Fiscal 2025, respectively.

Retail occupancy costs recorded in selling and administrative expenses were $74.4 million and $75.7 million for the third quarters of Fiscal 2026 and Fiscal 2025, respectively, and $220.8 million and $224.7 million for the first nine months of Fiscal 2026 and Fiscal 2025, respectively.

 

Advertising Costs

Advertising costs included in selling and administrative expenses were $37.1 million and $36.6 million for the third quarters of Fiscal 2026 and Fiscal 2025, respectively, and $92.1 million and $88.0 million for the first nine months of Fiscal 2026 and Fiscal 2025, respectively.

Vendor Allowances

Vendor reimbursements of cooperative advertising costs recognized as a reduction of selling and administrative expenses were $3.0 million and $3.1 million for the third quarters of Fiscal 2026 and Fiscal 2025, respectively, and $10.2 million and $7.7 million for the first nine months of

9


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 1

Summary of Significant Accounting Policies, Continued

Fiscal 2026 and Fiscal 2025, respectively. During the first nine months of each of Fiscal 2026 and Fiscal 2025, our cooperative advertising reimbursements received were not in excess of the costs incurred.

New Accounting Pronouncements

New Accounting Pronouncement Not Yet Adopted

In September 2025, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") 2025-06, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)." The ASU is intended to modernize the accounting for internal-use software costs with how software is developed today, clarify when to begin capitalizing costs and enhance disclosure requirements. The ASU is effective on either a retrospective, prospective or modified prospective basis for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years. Early adoption is permitted. We are currently evaluating the impact of the adoption of this ASU on our annual consolidated financial statements and interim condensed consolidated financial statements.

We continuously monitor and review all current accounting pronouncements and standards from the Financial Accounting Standards Board of U.S. GAAP for applicability to our operations and financial reporting. As of November 1, 2025, there were no other new pronouncements or interpretations, other than those disclosed above and in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025, that had or were expected to have a significant impact on our financial reporting.

Recent Tax Legislation

On July 4, 2025, H.R. 1, a bill to provide for reconciliation pursuant to title II of H. Con. Res. 14, informally known as the One Big Beautiful Bill Act ("OBBBA"), which includes several measures affecting corporations and other business entities, was signed into law. Among these measures, the OBBBA modifies and permanently extends certain expiring provisions of the 2017 Tax Cuts and Jobs Act (“TCJA”), including the restoration of 100% bonus depreciation, which was scheduled to phase out in 2027 under the TCJA. The OBBBA also permits immediate expensing of research and development expenditures previously capitalized under the TCJA and modifies various components of the international tax framework. The legislation has multiple effective dates, with some provisions taking effect in 2025 and others phased in through 2027. In accordance with Accounting Standards Codification (“ASC”) 740, “Income Taxes,” we recognized effects of the OBBBA during the second quarter of Fiscal 2026 for the provisions enacted at that point in time. For the fiscal year ending January 31, 2026, we anticipate a material decrease in our U.S. jurisdiction to both the current tax liability and the effective income tax rate as a result of the enactment of income tax law changes under the OBBBA and their interaction with our valuation allowance in the U.S. jurisdiction. Including the impact of the OBBBA tax law changes, we recorded an effective income tax rate of 10.3% in the first nine months of Fiscal 2026.

Note 2

Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill for the Journeys Group segment were as follows:

 

(In thousands)

Total
Goodwill

 

Balance, February 1, 2025

$

8,863

 

Effect of foreign currency exchange rates

 

313

 

Balance, November 1, 2025

$

9,176

 

 

10


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

 

Note 2

Goodwill and Other Intangible Assets, Continued

Other intangibles by major classes were as follows:

 

 

 

Trademarks

 

Customer Lists

 

 

Other

 

 

Total

 

(In thousands)

 

Nov. 1, 2025

 

 

Feb. 1, 2025

 

Nov. 1, 2025

 

 

Feb. 1, 2025

 

 

Nov. 1, 2025

 

 

Feb. 1, 2025

 

 

Nov. 1, 2025

 

 

Feb. 1, 2025

 

Gross other intangibles

 

$

25,210

 

 

$

23,839

 

$

6,552

 

 

$

6,471

 

 

$

400

 

 

$

400

 

 

$

32,162

 

 

$

30,710

 

Accumulated amortization

 

 

 

 

 

 

 

(4,757

)

 

 

(4,251

)

 

 

(400

)

 

 

(400

)

 

 

(5,157

)

 

 

(4,651

)

Net Other Intangibles

 

$

25,210

 

 

$

23,839

 

$

1,795

 

 

$

2,220

 

 

$

 

 

$

 

 

$

27,005

 

 

$

26,059

 

 

Note 3

Inventories

 

 

(In thousands)

 

November 1, 2025

 

 

February 1, 2025

 

Wholesale finished goods

 

$

64,357

 

 

$

82,784

 

Retail merchandise

 

 

493,702

 

 

 

342,440

 

Total Inventories

 

$

558,059

 

 

$

425,224

 

 

Note 4

Fair Value

Fair Value of Financial Instruments

The carrying amounts and fair values of our financial instruments at November 1, 2025 and February 1, 2025 are:

 

 

 

 

(In thousands)

November 1, 2025

 

February 1, 2025

 

 

Carrying
Amount

 

Fair
Value

 

Carrying
Amount

 

Fair
Value

 

U.S. Revolver Borrowings

$

69,774

 

$

69,795

 

$

 

$

 

U.K. Revolver Borrowings

 

19,727

 

 

19,737

 

 

 

 

 

Total Long-Term Debt

$

89,501

 

$

89,532

 

$

 

$

 

 

Debt fair values were determined using a discounted cash flow analysis based on current market interest rates for similar types of financial instruments and would be classified in Level 2 within the fair value hierarchy. We had $19.7 million of debt classified as current portion as of November 1, 2025 and no debt classified as current portion as of February 1, 2025.

 

As of November 1, 2025, we had $6.9 million of long-lived assets held and used which were measured using Level 3 inputs within the fair value hierarchy. As of November 1, 2025, we had $6.9 million of investments held and used which were measured using Level 1 inputs within the fair value hierarchy.

11


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 5

Long-Term Debt

 

The revolver borrowings outstanding under the Fourth Amended and Restated Credit Agreement dated as of January 31, 2018, as amended, between us, certain of our subsidiaries, the lenders party thereto and Bank of America, N.A. as agent (the "Credit Facility") as of November 1, 2025 included (i) $65.0 million U.S. revolver borrowings and (ii) $4.8 million (CAD $6.7 million) revolver borrowings related to GCO Canada ULC. In addition, we had revolver borrowings outstanding by and between Schuh and Lloyds Bank PLC (the "Facility Agreement") of $19.7 million (£15.0 million) as of November 1, 2025. The Facility Agreement was extended through February 28, 2026. We were in compliance with all the relevant terms and conditions of the Credit Facility and Facility Agreement as of November 1, 2025. Excess availability under the Credit Facility was $256.5 million at November 1, 2025.

Note 6

Earnings Per Share

Weighted-average number of shares used to calculate earnings per share are as follows:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

(Shares in thousands)

 

November 1, 2025

 

 

November 2, 2024

 

 

November 1, 2025

 

 

November 2, 2024

 

Weighted-average number of shares - basic

 

 

10,334

 

 

 

10,737

 

 

 

10,374

 

 

 

10,870

 

Common stock equivalents

 

 

340

 

 

 

-

 

 

 

-

 

 

 

-

 

Weighted-average number of shares - diluted

 

 

10,674

 

 

 

10,737

 

 

 

10,374

 

 

 

10,870

 

Common stock equivalents of 0.1 million shares are excluded for the three months ended November 2, 2024 and 0.2 million shares are excluded for each of the nine months ended November 1, 2025 and November 2, 2024 due to the loss from continuing operations in those periods.

We did not repurchase any shares of our common stock during the third quarter of Fiscal 2026. We repurchased 604,531 shares of our common stock during the first nine months of Fiscal 2026 at a cost of $12.6 million, or an average cost of $20.79 per share. As of November 1, 2025, we had $29.8 million remaining under our expanded share repurchase authorization announced in June 2023. We repurchased 17,922 shares of our common stock during the third quarter of Fiscal 2025 at a cost of $0.4 million, or an average cost of $24.50 per share, and repurchased 399,633 shares of common stock during the first nine months of Fiscal 2025 at a cost of $9.8 million, or an average cost of $24.49 per share. During the fourth quarter of Fiscal 2026, through December 11, 2025, we have not repurchased any shares of our common stock.

 

Note 7

Legal Proceedings

Environmental Matters

The Company has legacy obligations including environmental monitoring and reporting costs related to: (i) a 2016 Consent Judgment entered into with the United States Environmental Protection Agency involving the site of a knitting mill operated by a former subsidiary from 1965 to 1969 in Garden City, New York; and (ii) a 2010 Consent Decree with the Michigan Department of Natural Resources and Environment relating to our former Volunteer Leather Company facility in Whitehall, Michigan. We do not expect that future obligations related to either of these sites will have a material effect on our consolidated financial condition or results of operations.

 

Accrual for Environmental Contingencies

Related to all outstanding environmental contingencies, we had accrued $2.0 million as of November 1, 2025, $2.1 million as of February 1, 2025 and $1.9 million as of November 2, 2024. All such provisions reflect our estimates of the most likely cost (undiscounted, including both current and noncurrent portions) of resolving the contingencies, based on facts and circumstances as of the time they were made. There is no assurance that relevant facts and circumstances will not change, necessitating future changes to the provisions. Such contingent liabilities for discontinued operations are included in other accrued liabilities and other long-term liabilities on the accompanying Condensed Consolidated Balance Sheets because they relate to former facilities operated by us. We have made pretax accruals for certain of these contingencies which were not material for the third quarter of Fiscal 2026 or Fiscal 2025. These charges are included in loss from discontinued operations, net of tax in the Condensed Consolidated Statements of Operations and represent changes in estimates.

12


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 7

Legal Proceedings, Continued

In addition to the matters specifically described in this Note, we are a party to other legal and regulatory proceedings and claims arising in the ordinary course of our business. While management does not believe that our liability with respect to any of these other matters is likely to have a material effect on our Condensed Consolidated Financial Statements, legal proceedings are subject to inherent uncertainties, and unfavorable rulings could have a material adverse impact on our Condensed Consolidated Financial Statements.

 

Note 8

Business Segment Information

 

Three Months Ended November 1, 2025

 

 

 

 

 

 

(In thousands)

Journeys
Group

Schuh
Group

Johnston
& Murphy
Group

Genesco Brands Group

Corporate
& Other

Consolidated

Sales

$376,707

$123,766

$81,157

$34,587

$

$616,217

Intercompany sales elimination

Net sales to external customers(1)

376,707

123,766

81,157

34,587

616,217

Cost of sales

190,436

72,095

38,207

26,851

327,589

Gross margin

186,271

51,671

42,950

7,736

288,628

Selling and administrative expenses

165,705

51,002

43,545

7,195

8,273

275,720

Segment operating income (loss)

20,566

669

(595)

541

(8,273)

12,908

Asset impairments and other(2)

4,332

4,332

Operating income (loss)

20,566

669

(595)

541

(12,605)

8,576

Other components of net periodic benefit cost

149

149

Interest expense, net

884

884

Earnings (loss) from continuing operations before income taxes

$20,566

$669

$(595)

$541

$(13,638)

$7,543

Total assets (3)

$826,248

$226,909

$212,920

$57,107

$148,919

$1,472,103

Depreciation and amortization

8,258

2,054

1,783

349

917

13,361

Capital expenditures

12,637

1,547

4,096

60

265

18,605

 

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2026.

(2) Asset impairments and other includes a $3.9 million charge for store restructuring, including $3.6 million in Journeys Group and $0.3 million in Schuh Group, $0.2 million for severance and $0.2 million for asset impairments in Schuh Group.

(3) Of our $721.3 million of long-lived assets as of November 1, 2025, $91.1 million and $14.6 million relate to long-lived assets in the U.K. and Canada, respectively.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 8

Business Segment Information, Continued

 

Three Months Ended November 2, 2024

 

 

 

 

 

 

(In thousands)

Journeys
Group

Schuh
Group

Johnston
& Murphy
Group

Genesco Brands Group

Corporate
& Other

Consolidated

Sales

$362,517

$121,826

$78,463

$33,587

$

$596,393

Intercompany sales elimination

(65)

(65)

Net sales to external customers(1)

362,517

121,826

78,463

33,522

596,328

Cost of sales

184,068

69,477

35,895

21,632

311,072

Gross margin

178,449

52,349

42,568

11,890

285,256

Selling and administrative expenses

165,283

49,230

42,659

8,161

9,579

274,912

Segment operating income (loss)

13,166

3,119

(91)

3,729

(9,579)

10,344

Asset impairments and other (2)

134

134

Operating income (loss)

13,166

3,119

(91)

3,729

(9,713)

10,210

Other components of net periodic benefit cost

86

86

Interest expense, net

1,213

1,213

Earnings (loss) from continuing operations before income taxes

$13,166

$3,119

$(91)

$3,729

$(11,012)

$8,911

Total assets (3)

$746,432

$215,531

$178,166

$69,478

$225,914

$1,435,521

Depreciation and amortization

8,385

1,944

1,358

337

1,030

13,054

Capital expenditures

6,255

3,109

3,561

108

90

13,123

 

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales for the third quarter of Fiscal 2025.

(2) Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

(3) Of our $655.0 million of long-lived assets as of November 2, 2024, $93.7 million and $9.8 million relate to long-lived assets in the U.K. and Canada, respectively.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 8

Business Segment Information, Continued

 

Nine Months Ended November 1, 2025

 

 

 

 

 

 



(In thousands)

Journeys
Group

Schuh
Group

Johnston
& Murphy
Group

Genesco Brands Group

Corporate
& Other

Consolidated

Sales

$967,530

$346,276

$226,785

$95,564

$

$1,636,155

Intercompany sales elimination

Net sales to external customers(1)

967,530

346,276

226,785

95,564

1,636,155

Cost of sales

492,712

207,245

105,540

70,900

876,397

Gross margin

474,818

139,031

121,245

24,664

759,758

Selling and administrative expenses

474,534

144,504

123,122

22,772

24,088

789,020

Segment operating income (loss)

284

(5,473)

(1,877)

1,892

(24,088)

(29,262)

Asset impairments and other(2)

4,747

4,747

Operating income (loss)

284

(5,473)

(1,877)

1,892

(28,835)

(34,009)

Other components of net periodic benefit cost

477

477

Interest expense, net

3,682

3,682

Earnings (loss) from continuing
   operations before income taxes

$284

$(5,473)

$(1,877)

$1,892

$(32,994)

$(38,168)

Depreciation and amortization

$24,841

$6,107

$5,263

$1,037

$2,980

$40,228

Capital expenditures

30,739

7,521

13,104

200

621

52,185

 

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales for the first nine months of Fiscal 2026.

(2) Asset impairments and other includes a $3.9 million charge for store restructuring, including $3.6 million in Journeys Group and $0.3 million in Schuh Group, $0.6 million for severance and $0.2 million for asset impairments in Schuh Group.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 8

Business Segment Information, Continued

 

Nine Months Ended November 2, 2024

 

 

 

 

 

 



(In thousands)

Journeys
Group

Schuh
Group

Johnston
& Murphy
Group

Genesco Brands Group

Corporate
& Other

Consolidated

Sales

$920,808

$338,736

$228,707

$88,941

$

$1,577,192

Intercompany sales elimination(1)

1,921

1,921

Net sales to external customers(2)

920,808

338,736

228,707

90,862

$1,579,113

Cost of sales

469,486

195,777

106,277

60,397

831,937

Gross margin

451,322

142,959

122,430

30,465

747,176

Selling and administrative expenses

468,129

138,397

120,569

25,050

25,733

777,878

Segment operating income (loss)

(16,807)

4,562

1,861

5,415

(25,733)

(30,702)

Asset impairments and other(3)

1,490

1,490

Operating income (loss)

(16,807)

4,562

1,861

5,415

(27,223)

(32,192)

Other components of net periodic benefit cost

281

281

Interest expense

3,448

3,448

Earnings (loss) from continuing
   operations before income taxes

$(16,807)

$4,562

$1,861

$5,415

$(30,952)

$(35,921)

Depreciation and amortization

$25,545

$5,662

$4,136

$982

$3,135

$39,460

Capital expenditures

14,059

5,606

6,737

643

352

27,397

 

(1) Intercompany sales for the first nine months of Fiscal 2025 reflect net intercompany returns.

(2) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21% respectively, of our net sales for the first nine months of Fiscal 2025.

(3) Asset impairments and other includes a $0.5 million charge for asset impairments in Journeys Group and $1.0 million for severance.

 

16


 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

This section discusses management’s view of the financial condition, results of operations and cash flows of the Company. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025, including the Risk Factors section, and information contained elsewhere in this Quarterly Report on Form 10-Q, including the Condensed Consolidated Financial Statements and Notes to those financial statements. The results of operations for any interim period may not necessarily be indicative of the results that may be expected for any future interim period or the entire fiscal year.

Summary of Results of Operations

Our net sales increased 3.3% to $616.2 million in the third quarter of Fiscal 2026 compared to $596.3 million in the third quarter of Fiscal 2025. The net sales increase compared to last year's third quarter reflects a 3% increase in comparable sales, including a 5% increase in same store sales reflecting investment in and a strategic focus on the store channel as well as strong back-to-school sales in Journeys Group, an increase in wholesale sales and a favorable foreign exchange impact, partially offset by the impact of net store closings resulting from our store optimization efforts. The Journeys Group business had a strong third quarter of Fiscal 2026 with comparable sales up 6%, fueled by strength in the product assortment and other initiatives. Schuh Group comparable sales were down 2% for the third quarter of Fiscal 2026 reflecting the challenging retail environment in the U.K. Johnston & Murphy Group comparable sales were down 2% in the third quarter of Fiscal 2026 driven by softer e-commerce trends due to a shift in marketing spend. By segment, Journeys Group sales increased 4%, Schuh Group sales increased 2%, Johnston & Murphy Group sales increased 3% with higher wholesale sales offsetting the lower comparable sales and Genesco Brands Group sales increased 3% in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025. Schuh Group's sales decreased 1% on a local currency basis for the third quarter of Fiscal 2026.

 

Gross margin increased 1.2% to $288.6 million in the third quarter of Fiscal 2026 from $285.3 million in the third quarter of Fiscal 2025, but decreased as a percentage of net sales from 47.8% in the third quarter of Fiscal 2025 to 46.8% in the third quarter of Fiscal 2026. The overall decrease in gross margin as a percentage of net sales is due primarily to lower margins at Genesco Brands Group related to ongoing tariff pressure and the exit of licenses as well as increased promotional activity at Schuh Group, partially offset by lower shipping and warehouse costs for Journeys Group and Schuh Group.

Selling and administrative expenses in the third quarter of Fiscal 2026 increased 0.3% to $275.7 million from $274.9 million compared to the third quarter of Fiscal 2025, but decreased 140 basis points as a percentage of net sales in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 from 46.1% to 44.7%. The decrease as a percentage of net sales reflects decreased occupancy, freight and performance-based compensation expenses.

Operating margin was 1.4% in the third quarter of Fiscal 2026 compared to 1.7% in the third quarter of Fiscal 2025. The overall decrease in operating margin for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 primarily reflects decreased gross margin as a percentage of net sales and higher asset impairment and other charges, partially offset by decreased expenses as a percentage of net sales.

Earnings from continuing operations before income taxes (“pretax earnings”) for the third quarter of Fiscal 2026 was $7.5 million compared to $8.9 million for the third quarter of Fiscal 2025. Pretax earnings for the third quarter of Fiscal 2026 included asset impairment and other charges of $4.3 million for store restructuring, severance and asset impairments. Pretax earnings for the third quarter of Fiscal 2025 included a $0.1 million charge for asset impairments.

We had an effective income tax rate of 28.1% and 311.5% in the third quarter of Fiscal 2026 and Fiscal 2025, respectively. The lower effective tax rate in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 primarily reflects a $26.3 million U.S. valuation allowance recorded in the third quarter of Fiscal 2025.

Net earnings in the third quarter of Fiscal 2026 was $5.4 million, or $0.50 diluted earnings per share, compared to a net loss of $18.9 million, or $1.76 diluted loss per share, in the third quarter of Fiscal 2025.

Critical Accounting Estimates

We discuss our critical accounting estimates in Item 7, "Management’s Discussion and Analysis of Financial Condition and Results of Operations", in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. We describe our significant accounting policies in Note 1, "Summary of Significant Accounting Policies", of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. There have been no significant changes in our definition of significant accounting policies or critical accounting estimates since the end of Fiscal 2025.

17


 

 

Key Performance Indicators

In assessing the performance of our business, we consider a variety of performance and financial measures. The key performance indicators we use to evaluate the financial condition and operating performance of our business are comparable sales, net sales, gross margin, operating income and operating margin. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the U.S. GAAP financial measures presented herein. These measures may not be comparable to similarly titled performance indicators used by other companies.

Comparable Sales

We consider comparable sales to be an important indicator of our current performance, and investors may find it useful as such. Comparable sales results are important to achieve leveraging of our costs, including occupancy, selling salaries, depreciation and other costs. Comparable sales also have a direct impact on our total net revenue, working capital and cash. We define "comparable sales" as sales from stores open longer than one year, beginning with the first day a store has comparable sales (which we refer to as "same store sales"), and sales from websites operated longer than one year and direct mail catalog sales (which we refer to in this report as "comparable e-commerce sales"). Temporarily closed stores are excluded from the comparable sales calculation if closed for more than seven days. Expanded stores are excluded from the comparable sales calculation until the first day an expanded store has comparable prior year sales. Current year foreign exchange rates are applied to both current year and prior year comparable sales to achieve a consistent basis for comparison.

Operating Margin

Operating margin is a ratio calculated by dividing operating income (loss) by net sales. We believe operating margin provides investors with useful information related to the profitability of our business after considering all of the selling, general and administrative expenses and other operating charges incurred. We use this measure in making financial, operating and planning decisions and in evaluating our overall performance.

Results of Operations – Third Quarter of Fiscal 2026 Compared to Third Quarter of Fiscal 2025

 

Journeys Group

 

 

Three Months Ended

 

 

 

November 1, 2025

 

November 2, 2024

%
Change

 

 

(dollars in thousands)

 

Net sales

 

$376,707

 

$362,517

3.9%

Cost of sales

 

190,436

 

184,068

 

Gross margin

 

186,271

 

178,449

4.4%

  % of sales

 

49.4%

 

49.2%

 

Selling and administrative expenses

 

165,705

 

165,283

0.3%

  % of sales

 

44.0%

 

45.6%

 

Operating income

 

$20,566

 

$13,166

56.2%

Operating margin

 

5.5%

 

3.6%

 

 

Net sales from Journeys Group increased 3.9% to $376.7 million in the third quarter of Fiscal 2026, compared to $362.5 million in the third quarter of Fiscal 2025. The net sales increase compared to the third quarter of Fiscal 2025 reflects an increase in same store sales, partially offset by a 5% decrease in the average number of stores in the third quarter of Fiscal 2026 and a decrease in e-commerce comparable sales. The increased comparable sales in the third quarter of Fiscal 2026 was fueled by the continued strength in Journeys Group's product assortment and other initiatives. The Journeys Group consumer is more interested in a broader range of brands evidenced by what they are buying and by the more diversified styles they are wearing. Journeys Group's strong store performance was driven by gains in conversion and higher transaction size in the third quarter of Fiscal 2026.

 

We closed ten Journeys Group stores in the third quarter of Fiscal 2026. Journeys Group operated 974 stores at the end of the third quarter of Fiscal 2026, including 196 Journeys Kidz stores in the United States, 33 Journeys stores in Canada and 30 Little Burgundy stores in Canada, compared to 1,028 stores at the end of the third quarter of Fiscal 2025, including 218 Journeys Kidz stores in the United States, 37 Journeys stores in Canada and 30 Little Burgundy stores in Canada.

The 190 basis point improvement in operating margin for Journeys Group for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 was primarily due to a 160 basis point decrease in selling and administrative expenses as a percentage of net sales. This reflects leverage of expenses as a result of increased revenue in the third quarter of Fiscal 2026, especially occupancy expense and selling salaries, partially offset by increased marketing expense. In addition, gross margin as a percentage of net sales increased 20 basis points, reflecting

18


 

 

decreased shipping and warehouse expense and lower markdowns, partially offset by lower initial margins as a result of changes in brand mix. The decrease in selling and administrative expenses as a percentage of net sales demonstrates the impact of our cost savings initiatives and closing underperforming stores.

Schuh Group

 

 

Three Months Ended

 

 

 

November 1, 2025

 

November 2, 2024

%
Change

 

 

(dollars in thousands)

 

Net sales

 

$123,766

 

$121,826

1.6%

Cost of sales

 

72,095

 

69,477

 

Gross margin

 

51,671

 

52,349

(1.3)%

  % of sales

 

41.7%

 

43.0%

 

Selling and administrative expenses

 

51,002

 

49,230

3.6%

  % of sales

 

41.2%

 

40.4%

 

Operating income

 

$669

 

$3,119

(78.6)%

Operating margin

 

0.5%

 

2.6%

 

 

Net sales from Schuh Group increased 1.6% to $123.8 million in the third quarter of Fiscal 2026 compared to $121.8 million in the third quarter of Fiscal 2025. The net sales increase for the third quarter of Fiscal 2026 includes a favorable impact of $3.7 million due to changes in foreign exchange rates and increased e-commerce comparable sales, partially offset by decreased same store sales. Schuh Group total comparable sales decreased 2% for the third quarter of Fiscal 2026. Schuh Group continued to contend with a challenging U.K. retail environment in the third quarter of Fiscal 2026. Schuh Group's e-commerce business remains a key channel for consumer engagement, accounting for over 40% of its sales in the third quarter of Fiscal 2026. Schuh Group's sales decreased 1% on a local currency basis for the third quarter of Fiscal 2026. Schuh Group operated 119 stores at the end of the third quarter of Fiscal 2026, compared to 122 stores at the end of the third quarter of Fiscal 2025.

The 210 basis point decrease in operating margin for Schuh Group for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 was due to a 130 basis point decrease in gross margin as a percentage of net sales, reflecting increased promotional activity to match the competitive environment, partially offset by decreased shipping and warehouse expense. The decreased operating margin was also due to an 80 basis point increase in selling and administrative expenses as a percentage of net sales, reflecting deleverage of expenses in the third quarter of Fiscal 2026 on lower same store sales, especially selling salaries, professional fees and credit card expense, partially offset by decreased marketing expense.

Johnston & Murphy Group

 

 

Three Months Ended

 

 

 

November 1, 2025

 

November 2, 2024

%
Change

 

 

(dollars in thousands)

 

Net sales

 

$81,157

 

$78,463

3.4%

Cost of sales

 

38,207

 

35,895

 

Gross margin

 

42,950

 

42,568

0.9%

  % of sales

 

52.9%

 

54.3%

 

Selling and administrative expenses

 

43,545

 

42,659

2.1%

  % of sales

 

53.7%

 

54.4%

 

Operating loss

 

$(595)

 

$(91)

NM

Operating margin

 

(0.7)%

 

(0.1)%

 

 

Johnston & Murphy Group net sales increased 3.4% to $81.2 million for the third quarter of Fiscal 2026 from $78.5 million for the third quarter of Fiscal 2025, primarily due to increased wholesale sales, partially offset by a 2% decrease in comparable sales. The decline in comparable sales was primarily driven by softer e-commerce trends due to a shift in marketing spend. Retail operations accounted for 70.6% of Johnston & Murphy Group's sales in the third quarter of Fiscal 2026 versus 74.0% in the third quarter of Fiscal 2025. The store count for Johnston & Murphy Group's retail operations at the end of the third quarter of Fiscal 2026 and Fiscal 2025 was 152 full-price retail and factory stores. The store total at the end of the third quarter of Fiscal 2025 included five stores in Canada. Johnston & Murphy Group closed its five Canadian stores at the end of Fiscal 2025.

 

19


 

 

The 60 basis point decrease in operating margin for Johnston & Murphy Group for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 reflects primarily a 140 basis point decrease in gross margin as a percentage of net sales due to a higher mix of wholesale sales as well as tariff impacts ahead of price increases in the wholesale channel, partially offset by improved initial margins in the retail channel as a result of price increases. The decrease in operating margin was partially offset by a 70 basis point decrease in selling and administrative expenses as a percentage of net sales for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 primarily due to decreased marketing expense and selling salaries, partially offset by increased depreciation expense.

Genesco Brands Group

 

 

Three Months Ended

 

 

 

November 1, 2025

 

November 2, 2024

%
Change

 

 

(dollars in thousands)

 

Net sales

 

$34,587

 

$33,522

3.2%

Cost of sales

 

26,851

 

21,632

 

Gross margin

 

7,736

 

11,890

(34.9)%

  % of sales

 

22.4%

 

35.5%

 

Selling and administrative expenses

 

7,195

 

8,161

(11.8)%

  % of sales

 

20.8%

 

24.3%

 

Operating income

 

$541

 

$3,729

(85.5)%

Operating margin

 

1.6%

 

11.1%

 

 

Genesco Brands Group's net sales increased 3.2% to $34.6 million for the third quarter of Fiscal 2026 from $33.5 million for the third quarter of Fiscal 2025 primarily due to increased footwear sales of Dockers and private label, partially offset by decreased footwear sales of other licenses.

 

The decrease in operating margin for Genesco Brands Group for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 was primarily due to decreased gross margin as a percentage of net sales due to ongoing tariff pressure and higher closeout sales related to the exit of Levi's and other licenses. The decrease in operating margin was partially offset by decreased selling and administrative expenses as a percentage of net sales in the third quarter of Fiscal 2026 reflecting leverage of expenses as a result of increased revenue in the third quarter of Fiscal 2026, partially offset by increased professional fees and royalty expense.

Corporate, Interest Expenses and Other Charges

Corporate and other expense for the third quarter of Fiscal 2026 was $12.6 million compared to $9.7 million for the third quarter of Fiscal 2025. Corporate expense in the third quarter of Fiscal 2026 included asset impairment and other charges of $4.3 million for store restructuring, severance and asset impairments. Corporate expense in the third quarter of Fiscal 2025 included asset impairment and other charges of $0.1 million for asset impairments. The corporate expense decrease, excluding asset impairment and other charges, reflects decreased performance-based compensation expense in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025.

Net interest expense decreased 27.1% to $0.9 million in the third quarter of Fiscal 2026 compared to $1.2 million in the third quarter of Fiscal 2025 primarily reflecting decreased revolver borrowings in North America, partially offset by increased revolver borrowings in the U.K. in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025.

Results of Operations – First Nine Months of Fiscal 2026 Compared to First Nine Months of Fiscal 2025

Our net sales increased 3.6% to $1.64 billion in the first nine months of Fiscal 2026 compared to $1.58 billion in the first nine months of Fiscal 2025. The net sales increase compared to last year's first nine months reflects a 4% increase in comparable sales, including a 5% increase in same store sales reflecting investment in and a strategic focus on the store channel and a 1% increase in e-commerce comparable sales, a favorable foreign exchange impact and an increase in wholesale sales, partially offset by the impact of net store closings resulting from our store optimization efforts. The Journeys Group business was strong in the first nine months of Fiscal 2026 with comparable sales up 8%, fueled by strength in product assortment and other initiatives. Schuh Group comparable sales were down 2% for the first nine months of Fiscal 2026 reflecting the challenging retail environment in the U.K. Johnston & Murphy Group comparable sales were down 1% reflecting lower store sales in the first nine months of Fiscal 2026. By segment, Journeys Group sales increased 5%, Schuh Group sales increased 2% and Genesco Brands Group sales increased 5%, while Johnston & Murphy Group sales decreased 1% in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025. Schuh Group's sales decreased 2% on a local currency basis for the first nine months of Fiscal 2026.

 

Gross margin increased 1.7% to $759.8 million in the first nine months of Fiscal 2026 from $747.2 million in the first nine months of Fiscal 2025, but decreased as a percentage of net sales from 47.3% in the first nine months of Fiscal 2025 to 46.4% in the first nine months of Fiscal 2026. The overall decrease in gross margin as a percentage of net sales is due primarily to increased promotional activity at Schuh Group and

20


 

 

lower margins at Genesco Brands Group related to the exit of Levi's and other licenses and the impact from tariffs, partially offset by decreased shipping and warehouse expense in Journeys Group and Schuh Group.

Selling and administrative expenses in the first nine months of Fiscal 2026 increased 1.4% to $789.0 million from $777.9 million compared to the first nine months of Fiscal 2025, but decreased 110 basis points as a percentage of net sales in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 from 49.3% to 48.2%. The decrease as a percentage of net sales reflects decreased occupancy expense and other cost savings initiatives.

Operating margin was (2.1)% in the first nine months of Fiscal 2026 compared to (2.0)% in the first nine months of Fiscal 2025. The overall decrease in operating margin for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 primarily reflects decreased gross margin as a percentage of net sales and higher asset impairment and other charges, partially offset by decreased expenses as a percentage of net sales.

The loss from continuing operations before income taxes ("pretax loss") for the first nine months of Fiscal 2026 was $38.2 million compared to a pretax loss of $35.9 million for the first nine months of Fiscal 2025. The pretax loss for the first nine months of Fiscal 2026 included asset impairment and other charges of $4.7 million for store restructuring, severance and asset impairments. The pretax loss for the first nine months of Fiscal 2025 included a $1.8 million charge for a distribution model transition in the Genesco Brands Group and asset impairment and other charges of $1.5 million for severance and asset impairments.

We had an effective income tax rate of 10.3% and (47.7)% in the first nine months of Fiscal 2026 and Fiscal 2025, respectively. The higher effective tax rate in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 reflects a $26.3 million U.S. valuation allowance recorded in the third quarter of Fiscal 2025 and the enactment of income tax law changes under the OBBBA in Fiscal 2026 and their interaction with our valuation allowance in the U.S. jurisdiction.

The net loss in the first nine months of Fiscal 2026 was $34.3 million, or $3.31 diluted loss per share, compared to a net loss of $53.3 million, or $4.90 diluted loss per share, in the first nine months of Fiscal 2025.

 

Journeys Group

 

 

Nine Months Ended

 

 

 

 

November 1, 2025

 

November 2, 2024

 

%
Change

 

 

(dollars in thousands)

 

 

Net sales

 

$967,530

 

$920,808

 

5.1%

Cost of sales

 

492,712

 

469,486

 

 

Gross margin

 

474,818

 

451,322

 

5.2%

  % of sales

 

49.1%

 

49.0%

 

 

Selling and administrative expenses

 

474,534

 

468,129

 

1.4%

  % of sales

 

49.0%

 

50.8%

 

 

Operating income (loss)

 

$284

 

$(16,807)

 

NM

Operating margin

 

0.0%

 

(1.8)%

 

 

 

Net sales from Journeys Group increased 5.1% to $967.5 million in the first nine months of Fiscal 2026, compared to $920.8 million in the first nine months of Fiscal 2025. The net sales increase compared to the first nine months of Fiscal 2025 reflects an 8% increase in comparable sales, reflecting increased store sales, partially offset by a 5% decrease in the average number of stores in the first nine months of Fiscal 2026. The increased comparable sales in the first nine months of Fiscal 2026 was fueled by strength in Journeys Group's product assortment with brands across both casual and athletic posting strong gains and other initiatives. Journeys Group drove strong gains in conversion and transaction size for the first nine months this year.

The 180 basis point improvement in operating margin for Journeys Group for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 was due to decreased selling and administrative expenses as a percentage of net sales reflecting leverage of expense as a result of increased revenue in the first nine months of Fiscal 2026, especially occupancy expense and selling salaries. The improvement in operating margin was also due to an increase in gross margin as a percentage of net sales reflecting lower markdowns and decreased shipping and warehouse expense, partially offset by decreased initial margins as a result of changes in brand mix. The decrease in selling and administrative expenses as a percentage of net sales demonstrates the impact of our cost savings initiatives and closing underperforming stores.

21


 

 

Schuh Group

 

 

Nine Months Ended

 

 

 

 

November 1, 2025

 

November 2, 2024

 

%
Change

 

 

(dollars in thousands)

 

 

Net sales

 

$346,276

 

$338,736

 

2.2%

Cost of sales

 

207,245

 

195,777

 

 

Gross margin

 

139,031

 

142,959

 

(2.7)%

  % of sales

 

40.2%

 

42.2%

 

 

Selling and administrative expenses

 

144,504

 

138,397

 

4.4%

  % of sales

 

41.7%

 

40.9%

 

 

Operating income (loss)

 

$(5,473)

 

$4,562

 

NM

Operating margin

 

(1.6)%

 

1.3%

 

 

 

Net sales from Schuh Group increased 2.2% to $346.3 million in the first nine months of Fiscal 2026 compared to $338.7 million in the first nine months of Fiscal 2025. Net sales for the first nine months of Fiscal 2026 includes a favorable impact of $12.8 million due to changes in foreign exchange rates and an increase in e-commerce comparable sales, partially offset by decreased same store sales. Schuh Group performance was impacted by the ongoing challenging U.K. retail environment in the first nine months of Fiscal 2026. Schuh Group's e-commerce business remains a key channel for consumer engagement, accounting for over 40% of its sales in the first nine months of Fiscal 2026. Schuh Group total comparable sales decreased 2% for the first nine months of Fiscal 2026. Schuh Group's sales decreased 2% on a local currency basis for the first nine months of Fiscal 2026.

Operating margin decreased 290 basis points for Schuh Group for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 due to decreased gross margin as a percentage of net sales, reflecting increased promotional activity, including increased loyalty redemptions and promotions to match the competitive environment, and changes in brand mix, partially offset by decreased shipping and warehouse expenses. In addition, selling and administrative expenses increased as a percentage of net sales, reflecting deleverage of expenses, especially occupancy expense and selling salaries, partially offset by decreased compensation expense.

Johnston & Murphy Group

 

 

Nine Months Ended

 

 

 

 

November 1, 2025

 

November 2, 2024

 

%
Change

 

 

(dollars in thousands)

 

 

Net sales

 

$226,785

 

$228,707

 

(0.8)%

Cost of sales

 

105,540

 

106,277

 

 

Gross margin

 

121,245

 

122,430

 

(1.0)%

  % of sales

 

53.5%

 

53.5%

 

 

Selling and administrative expenses

 

123,122

 

120,569

 

2.1%

  % of sales

 

54.3%

 

52.7%

 

 

Operating income (loss)

 

$(1,877)

 

$1,861

 

NM

Operating margin

 

(0.8)%

 

0.8%

 

 

 

Johnston & Murphy Group net sales decreased 0.8% to $226.8 million for the first nine months of Fiscal 2026 from $228.7 million for the first nine months of Fiscal 2025, primarily due to decreased same store sales and a 3% decrease in the average number of stores in the first nine months of Fiscal 2026, partially offset by increased wholesale sales. Total comparable sales for Johnston & Murphy Group were down 1% for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025. Retail operations accounted for 74.9% of Johnston & Murphy Group's sales in the first nine months of Fiscal 2026 versus 76.0% in the first nine months of Fiscal 2025.

 

The 160 basis point decrease in operating margin for Johnston & Murphy Group for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 reflects increased selling and administrative expenses as a percentage of net sales for the first nine months of Fiscal 2026 primarily due to the deleverage of expenses, especially depreciation expense as a result of decreased revenue in the first nine months of Fiscal 2026. Gross margin as a percentage of net sales for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 was flat, as better retail margins were offset by lower wholesale margins due to tariff impacts ahead of price increases in the wholesale channel, a higher mix of wholesale sales and an increase in shipping and warehouse expense.

 

22


 

 

Genesco Brands Group

 

 

Nine Months Ended

 

 

 

 

November 1, 2025

 

November 2, 2024

 

%
Change

 

 

(dollars in thousands)

 

 

Net sales

 

$95,564

 

$90,862

 

5.2%

Cost of sales

 

70,900

 

60,397

 

 

Gross margin

 

24,664

 

30,465

 

(19.0)%

  % of sales

 

25.8%

 

33.5%

 

 

Selling and administrative expenses

 

22,772

 

25,050

 

(9.1)%

  % of sales

 

23.8%

 

27.6%

 

 

Operating income

 

$1,892

 

$5,415

 

(65.1)%

Operating margin

 

2.0%

 

6.0%

 

 

 

Genesco Brands Group's net sales increased 5.2% to $95.6 million for the first nine months of Fiscal 2026 from $90.9 million for the first nine months of Fiscal 2025 primarily due to increased sales of Levi's and private label footwear.

 

The decrease in operating margin for Genesco Brands Group for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 was primarily due to decreased gross margin as a percentage of net sales due to higher closeout sales related to the exit of Levi's and other licenses and the impact of tariffs as well as an unfavorable change in sales mix, partially offset by a $1.8 million inventory provision for a distribution model transition in the first nine months of Fiscal 2025. The decrease in operating margin was partially offset by decreased selling and administrative expenses as a percentage of net sales in the first nine months of Fiscal 2026 reflecting leverage of expenses as a result of increased revenue in the first nine months of Fiscal 2026 and decreased performance-based compensation expense.

Corporate, Interest Expenses and Other Charges

Corporate and other expense for the first nine months of Fiscal 2026 was $28.8 million compared to $27.2 million for the first nine months of Fiscal 2025. Corporate expense in the first nine months of Fiscal 2026 included asset impairment and other charges of $4.7 million for store restructuring, severance and asset impairments. Corporate expense in the first nine months of Fiscal 2025 included asset impairment and other charges of $1.5 million for severance and asset impairments. The corporate expense decrease, excluding asset impairment and other charges, reflects decreased performance-based compensation expense and professional fees in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025, partially offset by increased compensation.

Net interest expense increased 6.8% to $3.7 million in the first nine months of Fiscal 2026 compared to $3.4 million in the first nine months of Fiscal 2025 primarily reflecting increased revolver borrowings in the U.K. and lower interest income, partially offset by decreased revolver borrowings in North America in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025.

 

23


 

 

Liquidity and Capital Resources

Working Capital

Our business is seasonal, with our investment in working capital normally reaching peaks in the summer and fall of each year in anticipation of the back-to-school and holiday selling seasons. Historically, cash flows from operations typically have been generated principally in the fourth quarter of each fiscal year.

 

 

 

Nine Months Ended

Cash flow changes:

 

November 1, 2025

 

November 2, 2024

 

Increase
(Decrease)

(in thousands)

 

 

Net cash used in operating activities

 

$(27,597)

 

$(29,108)

 

$1,511

Net cash used in investing activities

 

(52,185)

 

(27,396)

 

(24,789)

Net cash provided by financing activities

 

72,435

 

54,543

 

17,892

Effect of foreign exchange rate fluctuations on cash

 

374

 

384

 

(10)

Net decrease in cash and cash equivalents

 

$(6,973)

 

$(1,577)

 

$(5,396)

 

Reasons for the major variances in cash provided by (used in) the table above are as follows:

Cash used in operating activities was $1.5 million lower in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025, reflecting primarily the following factors:

a $63.8 million increase in cash flow from changes in prepaids and other current assets, primarily reflecting the receipt of a $58.3 million income tax refund receivable; partially offset by

a $52.9 million decrease in cash flow from changes in accounts payable, primarily reflecting changes in buying patterns in the first nine months of Fiscal 2026.

 

Cash used in investing activities was $24.8 million higher for the first nine months of Fiscal 2026 as compared to the first nine months of Fiscal 2025 reflecting increased capital expenditures primarily related to investments in retail stores.

 

Cash provided by financing activities was $17.9 million higher in the first nine months of Fiscal 2026 as compared to the first nine months of Fiscal 2025 primarily reflecting increased net borrowings.

Sources of Liquidity and Future Capital Needs

We have three principal sources of liquidity: cash flow from operations, cash on hand and our credit facilities discussed in Item 8, Note 8, "Long-Term Debt", to our Consolidated Financial Statements included in our Annual Report on Form 10-K for Fiscal 2025.

As of November 1, 2025, we have borrowed $65.0 million U.S. revolver borrowings, $4.8 million (CAD $6.7 million) revolver borrowings related to GCO Canada ULC and $19.7 million (£15.0 million) related to Schuh revolver borrowings. The Facility Agreement in the U.K. was extended through February 28, 2026. We were in compliance with all the relevant terms and conditions of the Credit Facility and the Facility Agreement as of November 1, 2025.

We believe that cash on hand, cash provided by operations and borrowings under our Credit Facility and the Facility Agreement will be sufficient to support our liquidity needs in Fiscal 2026 and the foreseeable future.

On January 17, 2025, we executed Form 870 with the Internal Revenue Service ("IRS") exam team and began the process of completing the separate Joint Committee on Taxation ("JCT") review of our outstanding U.S. Federal tax refund claim for the Fiscal 2014 to Fiscal 2021 tax periods. As of February 1, 2025, we estimated the refund outstanding to be $59.3 million including interest. During the first quarter of Fiscal 2026, the JCT finalized their review with no changes to the claim and the IRS began the process of issuing the refund. The balance outstanding increased to $60.2 million as a result of additional accrued interest. We received $58.3 million of the refund during the second quarter of Fiscal 2026. The remaining $1.9 million outstanding represents additional interest not yet paid by the IRS as of November 1, 2025. As such, the $1.9 million receivable is classified as prepaids and other current assets on the Condensed Consolidated Balance Sheets as of November 1, 2025. We received $1.5 million of the remaining interest due from the IRS in November 2025 and expect to receive the majority of the remaining $0.4 million interest in the fourth quarter of Fiscal 2026.

24


 

 

Contractual Obligations

Our contractual obligations at November 1, 2025 increased 26% compared to February 1, 2025, primarily due to increased long-term debt and lease obligations.

Capital Expenditures

Total capital expenditures in Fiscal 2026 are expected to be approximately $55 to $65 million of which approximately 80% is for new stores and renovations and 20% is for other initiatives. We do not currently have any longer-term capital expenditures or other cash requirements other than as set forth above and in the contractual obligations table as disclosed in Item 7 of our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. We also do not currently have any off-balance sheet arrangements.

Common Stock Repurchases

We did not repurchase any shares of our common stock during the third quarter of Fiscal 2026. We repurchased 604,531 shares of our common stock during the first nine months of Fiscal 2026 at a cost of $12.6 million, or an average cost of $20.79 per share. We have $29.8 million remaining as of November 1, 2025 under our expanded share repurchase authorization announced in June 2023. We repurchased 17,922 shares of our common stock during the third quarter of Fiscal 2025 at a cost of $0.4 million, or an average cost of $24.50 per share, and repurchased 399,633 shares of common stock during the first nine months of Fiscal 2025 at a cost of $9.8 million, or an average cost of $24.49 per share. During the fourth quarter of Fiscal 2026, through December 11, 2025, we have not repurchased any shares of our common stock.

Environmental and Other Contingencies

We are subject to certain loss contingencies related to environmental proceedings and other legal matters, including those disclosed in Item 1, Note 7, "Legal Proceedings", to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

New Accounting Pronouncements

Descriptions of recently issued accounting pronouncements, if any, and the accounting pronouncements adopted by us during the third quarter of Fiscal 2026 are included in Note 1 to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We incorporate by reference the information regarding market risk appearing in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the heading “Financial Market Risk” in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. There have been no material changes to our exposure to market risks from those disclosed in the Annual Report on Form 10-K for the fiscal year ended February 1, 2025.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We have established disclosure controls and procedures designed to ensure that information required to be disclosed by us, including our consolidated subsidiaries, in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is made known to the officers who certify our financial reports and to other members of senior management. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired objectives.

Based on their evaluation as of November 1, 2025, the principal executive officer and principal financial officer of the Company have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within time periods specified in SEC rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our third quarter of Fiscal 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

25


 

 

PART II - OTHER INFORMATION

We incorporate by reference the information regarding legal proceedings in Item 1, Note 7, “Legal Proceedings”, to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

Reference is made to the factors set forth under the caption “Cautionary Notice Regarding Forward-Looking Statements” in this quarterly report on Form 10-Q and other risk factors described in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025, which are incorporated herein by reference. There have not been any material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended February 1, 2025, except as set forth below.

You should carefully consider these risk factors, all or any of which could materially affect our business, financial condition or future results. The risks described in this report and in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Government actions and regulations, including tariffs, export restrictions and other trade protection measures, may have a material adverse impact on our business.

The Company’s business is subject to risks related to tariffs and other trade policies put in place by the U.S. and/or other countries since most of the goods we sell are imported from outside the U.S. The goods sold through our retail businesses (approximately 80% of our sales) are sourced by our vendor partners and we directly source the goods sold by our branded businesses (approximately 20% of our sales). Over the past several years, we have worked to diversify our direct sourcing with a focus on reducing exposure to countries where tariffs are high and we have previously identified tariff and trade policy as a risk factor. In 2025, the U.S. government announced the imposition of additional tariffs on certain goods imported from numerous countries, including China, Brazil, India and Vietnam. Multiple nations, including China, responded with reciprocal tariffs and other trade actions. The recent enactment of tariffs by the U.S. government, along with the unpredictability of the rates and other potential actions that may be taken by the U.S. government and foreign governments (including trade restrictions, new or increased tariffs or quotas, embargoes, sanctions and counter sanctions, safeguards or customs restrictions) may materially increase our costs and reduce our margins. These actions may also lead to higher pricing for our products, potentially reducing consumer demand and impacting our sales. We are actively monitoring the impact of any tariffs that become effective, as well as potential retaliatory actions by other countries. We are currently taking actions to mitigate this cost pressure, including accelerating, increasing or canceling inventory, further diversifying suppliers and re-sourcing to countries with lower tariffs, working with longstanding factory partners to reduce costs, identifying further cost reductions across our business and planning for strategic price increases. However, there can be no assurance that we will be able to implement any strategies in a timely fashion, that these measures will be successful, or that they will offset the negative impact of the tariffs and other government actions on our business.

Given the uncertainty regarding scope and duration of the current and potential tariffs, as well as the potential for additional trade actions by the U.S. or other countries, the specific impact to our business, results of operations, cash flows and financial condition is uncertain but could be material.

 

26


 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Repurchases (shown in thousands except share and per share amounts):

 

ISSUER PURCHASES OF EQUITY SECURITIES

 

 

 

 

 

 

 

 

 

 

Period

(a) Total
Number of
Shares
Purchased

 

(b) Average
Price
Paid
per Share

 

(c) Total
Number of
Shares
Purchased
as Part
of Publicly
Announced
Plans or
Programs

 

(d) Maximum
Number
(or Approximate
Dollar Value)
of Shares that
May Yet Be
Purchased
Under the
Plans or
Programs

 

August 2025

 

 

 

 

 

 

 

 

8-3-25 to 8-30-25(1)

 

 

$

 

 

 

$

29,755

 

8-3-25 to 8-30-25(2)

 

342

 

$

24.49

 

 

 

 

 

 

 

 

 

 

 

 

 

September 2025

 

 

 

 

 

 

 

 

8-31-25 to 9-27-25(1)

 

 

$

 

 

 

$

29,755

 

 

 

 

 

 

 

 

 

October 2025

 

 

 

 

 

 

 

 

9-28-25 to 11-1-25 (1)

 

 

$

 

 

 

$

29,755

 

9-28-25 to 11-1-25 (2)

 

1,296

 

$

29.83

 

 

 

 

 

Total

 

1,638

 

$

28.71

 

 

 

$

29,755

 

 

 

 

 

 

 

 

 

 

(1) Share repurchases were made pursuant to a $100.0 million share repurchase program approved by our Board of Directors and announced in February 2022, and in June 2023, our Board of Directors approved an additional $50.0 million for share repurchases. We expect to implement the balance of the repurchase program through purchases made from time to time either in the open market or through private transactions, in accordance with the regulations of the SEC and other applicable legal requirements. The timing and amount of any shares repurchased under the program will depend on a variety of factors, including price, corporate and regulatory requirements, capital availability, and other market conditions. The repurchase program may be limited, temporarily paused, or terminated by our Board of Directors at any time without prior notice.

 

(2) These shares represent shares withheld from vested restricted stock to satisfy the minimum withholding requirement for federal and state taxes.

 

 

Item 5. Other Information

 

Insider Trading Arrangements

 

During the third quarter of Fiscal 2026, no director or officer (as defined in Section 16 of the Exchange Act) of the Company adopted or terminated any "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (in each case, as defined in Item 408 (a) and (c) of Regulation S-K).

 

 

 

 

 

 

 

 

 

 

 

27


 

 

Item 6. Exhibits

 

Exhibit Index

 

 

 

 

 

 

31.1

Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1

Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2

Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101

The following materials from Genesco Inc.'s Quarterly Report on Form 10-Q for the quarter ended November 1, 2025, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets at November 1, 2025, February 1, 2025 and November 2, 2024, (ii) Condensed Consolidated Statements of Operations for each of the three and nine months ended November 1, 2025 and November 2, 2024, (iii) Condensed Consolidated Statements of Comprehensive Income (Loss) for each of the three and nine months ended November 1, 2025 and November 2, 2024, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended November 1, 2025 and November 2, 2024, (v) Condensed Consolidated Statements of Equity for each of the three and nine months ended November 1, 2025 and November 2, 2024, and (vi) Notes to the Condensed Consolidated Financial Statements.

 

 

 

 

 

 

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

28


 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

Genesco Inc.

 

 

 

 

By:

 

/s/ Cassandra E. Harris

 

 

 

Cassandra E. Harris

 

 

 

Senior Vice President - Finance and

Chief Financial Officer

 

 

 

 

 

Date: December 11, 2025

 

29


FAQ

How did Genesco Inc. (GCO) perform in the third quarter of Fiscal 2026?

In the third quarter of Fiscal 2026, Genesco generated net sales of $616.2 million, up 3.3% year over year, and reported net earnings of $5.4 million, or $0.50 diluted earnings per share, compared with a net loss of $18.9 million, or $1.76 diluted loss per share, in the prior-year quarter.

Which segments drove Genesco Inc. (GCO) sales growth in the quarter?

Journeys Group was the main growth driver, with net sales increasing 3.9% to $376.7 million and a 6% comparable sales increase. Schuh Group sales rose 1.6% to $123.8 million, Johnston & Murphy Group grew 3.4% to $81.2 million, and Genesco Brands Group increased 3.2% to $34.6 million.

What happened to Genesco Inc. (GCO) margins in the third quarter of Fiscal 2026?

Gross margin increased slightly to $288.6 million but declined as a percentage of sales from 47.8% to 46.8%, mainly due to tariff-related pressure and higher promotions, especially at Genesco Brands and Schuh. Operating margin fell from 1.7% to 1.4%, reflecting these margin pressures and higher restructuring and impairment charges.

How is Genesco Inc. (GCO) managing its store base and restructuring efforts?

Genesco continues its store optimization strategy, including closing underperforming locations. In the third quarter of Fiscal 2026, Journeys Group closed ten stores, ending the period with 974 locations. The company recorded $4.3 million of asset impairment and other charges in the quarter and $4.7 million for the first nine months, largely related to store restructuring, severance and asset impairments.

What is the impact of recent U.S. tax law changes on Genesco Inc. (GCO)?

The OBBBA legislation restored 100% bonus depreciation and allowed immediate expensing of certain research and development costs. Genesco recognized the effects during Fiscal 2026, contributing to a lower effective income tax rate of 10.3% for the first nine months and a material decrease in its U.S. current tax liability. The company also received $58.3 million of a U.S. tax refund in the period.

What is Genesco Inc. (GCO)'s liquidity and debt position as of November 1, 2025?

As of November 1, 2025, Genesco had total assets of $1.47 billion, with long-term debt of $89.5 million, including $65.0 million in U.S. revolver borrowings, $4.8 million (CAD $6.7 million) related to GCO Canada ULC, and $19.7 million (£15.0 million) under the Schuh Facility Agreement. Excess availability under the main Credit Facility was $256.5 million.

Did Genesco Inc. (GCO) repurchase any common stock in Fiscal 2026 year-to-date?

Genesco did not repurchase shares in the third quarter of Fiscal 2026, but during the first nine months it repurchased 604,531 shares at a total cost of $12.6 million, or an average price of $20.79 per share. As of November 1, 2025, $29.8 million remained under the existing share repurchase authorization.

Genesco

NYSE:GCO

GCO Rankings

GCO Latest News

GCO Latest SEC Filings

GCO Stock Data

261.57M
9.82M
8.94%
104.98%
9.12%
Apparel Retail
Retail-shoe Stores
Link
United States
NASHVILLE